Inactive Instrument

Press Releases IPI Legacy Liquidation Co

Equities

IMPL

US45258K1097

Delayed OTC Markets Other stock markets 19:08:57 05/04/2024 BST			5-day change	1st Jan Change
0.015 ^USD	-.--%		-.--%	-87.85%

04-12	North American Morning Briefing : Big Banks Kick -2-	DJ
04-05	North American Morning Briefing : Investors on -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Impel Pharmaceuticals : ORDER (I) APPROVING NOTIFICATION AND HEARING PROCEDURES FOR CERTAIN TRANSFERS OF AND DECLARATION OF WORTHLESSNESS WITH RESPECT TO COMMON STOCK AND (II) GRANTING RELATED RELIEF - Form 8-K	01-02	PU
Impel Pharmaceuticals : Announces Filing Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate Sale - Form 8-K	12-20	PU
Impel Pharmaceuticals Announces Exploration of Strategic Alternatives	05/10/23	GL
Impel Pharmaceuticals Announces Exploration of Strategic Alternatives	05/10/23	AQ
Thinking about buying stock in Workhorse Group, Canoo, Aurora Innovation, Plug Power, or Impel Pharmaceuticals?	05/07/23	PR
Impel Pharmaceuticals to Present New Real-World Data for Trudhesa at the 65th Annual Scientific Meeting of the American Headache Society	16/06/23	AQ
Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society	15/06/23	GL
Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society	15/06/23	AQ
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update	15/05/23	AQ
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update	12/05/23	GL
IMPEL PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	10/05/23	AQ
Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer	10/05/23	GL
Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023	05/05/23	GL
Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023	05/05/23	AQ
Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications	26/04/23	GL
IMPEL PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	17/04/23	AQ
IMPEL PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	12/04/23	AQ
Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors	12/04/23	GL
Impel Pharmaceuticals to Present Data on Trudhesa Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting	12/04/23	AQ
Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting	11/04/23	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IPI Legacy Liquidation Co

Equities

IMPL

US45258K1097

Press Releases

Filters